From the Food and Drug Administration.
Nightingale
S L
SL
D019440:Anti-Obesity Agents; D001803:Blood Transfusion / Q000295:instrumentation*; D017277:Drug Approval; D004868:Equipment Failure; D006801:Humans; D007022:Hypotension / Q000209:etiology*; D007783:Lactones; D007937:Leukapheresis / Q000009:adverse effects / Q000295:instrumentation*; D008049:Lipase / Q000037:antagonists & inhibitors*; D000077403:Orlistat; D011358:Product Surveillance, Postmarketing; D065227:Transfusion Reaction; D014481:United States; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat; D008049:Lipase